Paradoxical emboli from calf and pelvic veins in cryptogenic stroke

Journal of Neuroimaging

Volumn 13, Issue 3, 2003, Pages 218-223

  Cramer, Steven C ^c   Maki, Jeffrey H ^d   Waitches, Gayle M ^d   D'Souza, Neisha ^d   Grotta, James C ^a   Burgin, W Scott ^a   Kramer, Larry A ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

Cryptogenic stroke; Deep venous thrombosis; Paradoxical embolism; Patent foramen ovale

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ORAL CONTRACEPTIVE AGENT; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TEST; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CRYPTOGENIC STROKE; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; DISEASE PREDISPOSITION; EVALUATION; FEMALE; FEMORAL VEIN; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPERCOAGULABILITY; IMAGE ANALYSIS; LEG VEIN; LUNG EMBOLISM; MALE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARADOXICAL EMBOLISM; PELVIS VEIN; PHLEBOGRAPHY; POPLITEAL VEIN; STROKE; SUBDIAPHRAGMATIC VEIN; VEIN; VENOUS CIRCULATION;

ADULT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; EMBOLISM, PARADOXICAL; FEMALE; HUMANS; LEG; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PELVIS; VEINS; VENOUS THROMBOSIS;

EID: 0038460833     PISSN: 10512284     EISSN: None     Source Type: Journal    
DOI: 10.1177/1051228403013003003     Document Type: Article

References (42)

1. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989;25:382-390.
2. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (Danaparoid), and outcome after acute ischemic stroke. J Am Med Assoc 1998;279:1265-1272.
3. Mohr JP, Thompson JLP, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444-1451.
4. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993;24:1865-1873.
5. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
6. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461-465.
7. Jeanrenaud X, Bogousslavsky J, Payot M, Regli F, Kappenberger L. Patent foramen ovale and cerebral infarct in young patients. Schweiz Med Wochenschr 1990;120:823-829.
8. Lechat P, Mas JL, Lascault G. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
9. Steiner MM, Di Tullio MR, Rundek T, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998;29:944-948.
10. Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988;1988:11-12.
11. Petty GW, Khandheria BK, Chu C-P, Sicks JD, Whisnant JP. Patent foramen ovale in patients with cerebral infarction. Arch Neurol 1997;54:819-822.
12. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994;25:582-586.
13. Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001;38:613-623.
14. Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000;109:456-462.
15. Mas J-L, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
16. Schuchlenz HW, Saurer G, Weihs W. Patent foramen ovale, atrial septal aneurysm, and recurrent stroke. N Engl J Med 2002;346:1331-1332.
17. Warlow C, Ogston D, Douglas AS. Deep venous thrombosis of the legs after strokes. Br Med J 1976;1:1178-1183.
18. Falk RH. PFO or UFO? The role of a patent foramen ovale in cryptogenic stroke. Am Heart J 1991;121:1264-1266.
19. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebisher N, Van Melle G, the Lausanne Stroke with Paradoxical Embolism Study Group. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Neurology 1996;46:1301-1305.
20. Lethen H, Flachskampf FA, Schneider R, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 1997;80:1066-1069.
21. Stollberger C, Slany J, Schuster I, Leitner H, Winkler WB, Karnik R. The prevalence of deep vein thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 1993;119:461-465.
22. Gautier JC, Durr A, Koussa S, Lasault G, Grosgogeat T. Paradoxical cerebral embolism with a patent foramen ovale. Cerebrovasc Dis 1991;1:193-202.
23. Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL. Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 1993;24:31-34.
24. Bergqvist D, Bergentz S-E. Diagnosis of deep vein thrombosis. World J Surg 1990;14:679-687.
25. Wheeler HB, Anderson FA. Diagnostic methods for deep vein thrombosis. Haemostasis 1995;25:6-26.
26. Corrin B. Paradoxical embolism. Br Heart J 1964;26:549-553.
27. Johnson BI. Paradoxical emboli. J Clin Pathol 1951;4:316-332.
28. Modan B, Sharon E, Jelin N. Factors contributing to the incorrect diagnosis of pulmonary embolic disease. Chest 1972;62:388-393.
29. Spritzer CE, Arata MA, Freed KS. Isolated pelvic deep venous thrombosis: relative frequency as detected with MR imaging. Radiology 2001;219:521-525.
30. Kelly J, Rudd A, Lewis R, Hunt BJ. Venous thromboembolism after acute stroke. Stroke 2001;32:262-267.
31. Cramer SC, Rordorf G, Kaufman JA, Buonanno F, Koroshetz WJ, Schwamm L. Clinically occult pelvic-vein thrombosis in cryptogenic stroke. Lancet 1998;351:1927-1928.
32. Greer DM, Buonanno FS. Cerebral infarction in conjunction with patent foramen ovale and May-Thurner syndrome. J Neuroimaging 2001;11:432-434.
33. Landi G, D'Angelo A, Boccardi E, et al. Venous thromboembolism in acute stroke: prognostic importance of hypercoagulability. Arch Neurol 1992;49:279-283.
34. Havig O. Deep vein thrombosis. Acta Chirurgica Scandinavica 1977;478(suppl):4-11.
35. Philbrick JT, Becker DM. Calf deep venous thrombosis. A wolf in sheep's clothing? Arch Intern Med 1988;148:2131-2138.
36. Lohr JM, James KV, Deshmukh RM, Hasselfeld KA. Allastair B. Karmody Award. Calf vein thrombi are not a benign finding. Am J Surg 1995;170:86-90.
37. Havig O. Source of pulmonary emboli. Acta Chirurgica Scandinavica 1977;478(suppl):42-47.
38. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 1996;93:2212-2245.
39. Salzman EW. Venous thrombosis made easy. N Engl J Med 1986;314:847-848.
40. Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med 1998;129:1044-1049.
41. Mohr JP. Cryptogenic stroke. New Engl J Med 1988;318:1197-1198.
42. Schuchlenz HW, Weihs W, Beitzke A, Stein JI, Gamillscheg A, Rehak P. Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events. Stroke 2002;33:293-296.